Healthcare & Life Sciences
India operating intelligence and execution for Healthcare & Life Sciences.
India Healthcare & Life Sciences — the institutional view
Healthcare in India spans hospitals, diagnostics, devices, pharma, biotech, and digital health — each with distinct entry pathways and regulatory architectures.
NirjiX partners with global hospital chains, medtech leaders, diagnostics platforms, and pharma manufacturers entering or scaling in India.
We coordinate CDSCO, NPPA, and ICMR alongside commercial launch, manufacturing, and clinical talent.
How NirjiX engages
Hospitals Entering India
Hospital chain India entry — site selection, regulatory, clinical talent, and partnership architecture.
Diagnostics
Diagnostics platforms — labs, point-of-care, AI diagnostics — entry, expansion, and operating scale.
Medical Devices
Medical device entry — regulatory, distribution, KOL engagement, and manufacturing.
Healthcare Manufacturing
Regulated medical device, pharma, and biologics manufacturing at India scale.
Regulatory Support
CDSCO, NPPA, ICMR, and state regulator coordination.
Healthcare GTM
Hospital sales, diagnostics distribution, pharma launch, and clinical adoption.
Where we operate
- Site & partnership
- Clinical talent
- Operating model
- CDSCO coordination
- Distribution
- KOL engagement
- Lab network
- Point-of-care
- AI diagnostics
- Manufacturing
- Clinical trials
- Distribution
- R&D centers
- Clinical operations
- Regulatory
- Platform GTM
- Hospital partnerships
- Reimbursement
Cross-border corridors
| Region | Cross-border focus into India |
|---|---|
| United States | US medtech, diagnostics, digital health India entry and operations. |
| Europe | European pharma, biotech, and medtech India expansion. |
| Japan | Japanese medical device and diagnostics India operations. |
| Middle East | Hospital chains and healthcare investors expanding into India. |
| South Korea | Korean medical device and aesthetic healthcare entry. |
Frequently asked
How does CDSCO regulation work for medical devices?+
CDSCO classifies devices and requires registration through MD-9/MD-15 pathways. NirjiX coordinates classification, registration, and post-market surveillance.
Can you support hospital chain entry?+
Yes — partnership architecture, site selection, regulatory, clinical talent, and operating model design.
Do you manufacture medical devices in India?+
We architect medical device manufacturing — site selection, regulatory, capex governance, and operating scale.
Build your India Healthcare & Life Sciences strategy with NirjiX.
Sector-native execution, institutional governance, and cross-border operating depth.